Study of Dupilumab for the Treatment of Patients With Prurigo Nodularis, Inadequately Controlled on Topical Prescription Therapies or When Those Therapies Are Not Advisable (LIBERTY-PN PRIME)

Investigational Site Number :4100007, Seongnam-si

Investigational Site Number :8400010, Philadelphia

Investigational Site Number :4100005, Incheon

Investigational Site Number :4100001, Incheon

Investigational Site Number :8400005, Norfolk

Investigational Site Number :8400015, Charleston

Investigational Site Number :8400003, Newnan

Investigational Site Number :8400017, Sandy Springs

Investigational Site Number :8400004, Columbus

Investigational Site Number :8400014, Miami

Investigational Site Number :8400001, Dublin

Investigational Site Number :4840002, Guadalajara

Investigational Site Number :4840006, Guadalajara

Investigational Site Number :8400009, Athens

Investigational Site Number :8400016, Indianapolis

Investigational Site Number :8400018, Clarkston

Investigational Site Number :2500005, Reims

Investigational Site Number :8400013, St Louis

Investigational Site Number :4840001, Monterrey

Investigational Site Number :4840005, Monterrey

Investigational Site Number :8400022, Fort Smith

Investigational Site Number :8400007, Tulsa

Investigational Site Number :8400025, Houston

Investigational Site Number :8400006, Bellaire

Investigational Site Number :8400019, San Antonio

Investigational Site Number :8400002, Pflugerville

Investigational Site Number :8400011, Gilbert

Investigational Site Number :4840003, Veracruz

Investigational Site Number :8400026, Sacramento

Investigational Site Number :1560004, Beijing

Investigational Site Number :6430005, Moscow

Investigational Site Number :6430010, Moscow

Investigational Site Number :6430006, Moscow

Investigational Site Number :6430002, Saint Petersburg

Investigational Site Number :1560003, Wuxi

Investigational Site Number :1560002, Hangzhou

Investigational Site Number :6430007, Krasnodar

Investigational Site Number :6430001, Stavropol

Investigational Site Number :6430009, Saratov

Investigational Site Number :6430008, Chelyabinsk

Investigational Site Number :1560001, Chengdu

Investigational Site Number :8400024, East Windsor

Investigational Site Number :0320008, CABA

Investigational Site Number :0320005, CABA

Investigational Site Number :0320002, CABA

Investigational Site Number :0320004, CABA

Investigational Site Number :0320007, CABA

Investigational Site Number :0320003, San Miguel de Tucumán

Investigational Site Number :0320001, Buenos Aires

Investigational Site Number :0320006, Caba

Investigational Site Number :0320009, Mendoza

Investigational Site Number :3920009, Yokohama

Investigational Site Number :3920005, Kyoto

Investigational Site Number :3920007, Nagasaki

Investigational Site Number :3920003, Tokorozawa-shi

Investigational Site Number :3920010, Izumo-shi

Investigational Site Number :3920004, Bunkyo-ku

Investigational Site Number :3920006, Itabashi-ku

Investigational Site Number :3920001, Shinagawa-Ku

Investigational Site Number :3920002, Nagoya

Investigational Site Number :4100002, Seoul

Investigational Site Number :4100003, Seoul

Investigational Site Number :4100004, Seoul